Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in refractory Behcet disease uveitis and concomitant bladder papillary carcinoma.

, , , , ,

Internal medicine journal Vol. 47 (9) : 1086-1088 • Sep 2017

No abstract available for this paper

No clinical trial protocols linked to this paper

Clinical trials are automatically linked when NCT numbers are found in the paper's title or abstract.

PICO extraction requires an abstract.

PMID: 28891187

DOI: 10.1111/imj.13538 [doi]

Publication Year: 2017

Language: e, n, g

No associated datasets or code repositories found for this paper.

Related paper suggestions will be available in future updates.